LRP5: A Multifaceted Co-Receptor in Development, Disease, and Therapeutic Target
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Low-density lipoprotein receptor-related protein 5 (LRP5) is crucial for development and disease, impacting bone, eye, kidney, and metabolism. Modulating LRP5 offers therapeutic potential across various conditions.
Area Of Science
- Biochemistry
- Molecular Biology
- Genetics
Background
- Low-density lipoprotein receptor-related protein 5 (LRP5) is a key transmembrane coreceptor.
- LRP5 primarily signals through the Wnt/β-catenin pathway but also noncanonical pathways (AKT/P21, TGF-β/Smad).
- Mutations in LRP5 cause skeletal disorders like osteoporosis-pseudoglioma syndrome and high bone mass.
Purpose Of The Study
- To review the multifaceted roles of LRP5 in physiological processes and disease pathogenesis.
- To explore LRP5's involvement across various organ systems, including skeletal, ocular, renal, and metabolic.
- To highlight LRP5's therapeutic potential and the need for targeted modulation strategies.
Main Methods
- Literature review of LRP5 functions and associated signaling pathways.
- Analysis of LRP5's role in both normal development and pathological conditions.
- Examination of current and emerging therapeutic strategies targeting LRP5.
Main Results
- LRP5 regulates retinal angiogenesis, vascular integrity, renal function, neurodevelopment, and lipid metabolism.
- LRP5 exhibits a dual role, protecting against acute injury but contributing to chronic diseases via fibrosis and inflammation.
- LRP5 influences adipocyte differentiation, insulin sensitivity, and neuronal plasticity.
Conclusions
- LRP5 is a critical regulator with diverse functions across multiple organ systems.
- LRP5's involvement in both protective and detrimental pathways necessitates context-specific therapeutic approaches.
- Targeting LRP5 presents promising therapeutic avenues for a range of diseases.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor tyrosine kinases:
Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...